Journals / Molecular Imaging and Radionuclide Therapy / 2016 / Cilt: 25 - Sayı: 2

Evaluation of Silent Myocardial Ischemia with Single-Photon Emission Computed Tomography/Computed Tomography in Asymptomatic Subjects with Diabetes and Pre-Diabetes

Asemptomatik Diyabetik ve Pre-Diyabetik Hastalarda Miyokardiyal Sessiz İskeminin Tek Foton Emisyon Bilgisayarlı Tomografi/Bilgisayarlı Tomografi ile Değerlendirilmesi

Pages
70–78
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Patients with ischemia were significantly more likely to have ACCE during follow-up as compared to those with normal MPI scans (event rates: 21.4% vs. 3.1%, OR: 8.455 95% CI: 1.264-56.562, p=0.038).Conclusion: Myocardial ischemia as detected by adenosine stress SPECT/CT in a population of asymptomatic patients with diabetes mellitus or pre-diabetes appeared to predict the occurrence of ACCE at follow-up.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of this study was to disclose the prevalence of myocardial ischemia, as detected by adenosine stress myocardial perfusion imaging (MPI) with hybrid single-photon emission computed tomography/computed tomography (SPECT/CT), in asymptomatic diabetic and pre-diabetic patients and to find out whether ischemia predicted the occurrence of adverse cardiac/cerebrovascular events (ACCE) at follow-up.
📊
Key Findings & Data:Methods: Forty-three diabetic and thirty-five pre-diabetic asymptomatic patients without any history of coronary artery disease, underwent MPI and were followed-up for a 12.8±2.2 months for the occurrence of ACCE.
💡
Conclusion & Impact:Patients with ischemia were significantly more likely to have ACCE during follow-up as compared to those with normal MPI scans (event rates: 21.4% vs. 3.1%, OR: 8.455 95% CI: 1.264-56.562, p=0.038).Conclusion: Myocardial ischemia as detected by adenosine stress SPECT/CT in a population of asymptomatic patients with diabetes mellitus or pre-diabetes appeared to predict the occurrence of ACCE at follow-up.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The aim of this study was to disclose the prevalence of myocardial ischemia, as detected by adenosine stress myocardial perfusion imaging (MPI) with hybrid single-photon emission computed tomography/computed tomography (SPECT/CT), in asymptomatic diabetic and pre-diabetic patients and to find out whether ischemia predicted the occurrence of adverse cardiac/cerebrovascular events (ACCE) at follow-up. Methods: Forty-three diabetic and thirty-five pre-diabetic asymptomatic patients without any history of coronary artery disease, underwent MPI and were followed-up for a 12.8±2.2 months for the occurrence of ACCE. Baseline variables that would predict the presence of ischemia and the value of ischemia on MPI for predicting the occurrence of ACCE at followup were evaluated by logistic regression analysis. Results: Ischemia was detected in ten (23.3%) of the diabetic and in four (11.4%) of the pre-diabetic patients. The presence of diabetes was the only independent predictor of myocardial ischemia [odds ratio (OR): 12.31, 95% confidence interval (CI): 1.83-82.66; p<0.01]. During 12.8±2.2 months of follow-up, ACCE was observed in five out of 78 (6.4%) patients. Patients with ischemia were significantly more likely to have ACCE during follow-up as compared to those with normal MPI scans (event rates: 21.4% vs. 3.1%, OR: 8.455 95% CI: 1.264-56.562, p=0.038).Conclusion: Myocardial ischemia as detected by adenosine stress SPECT/CT in a population of asymptomatic patients with diabetes mellitus or pre-diabetes appeared to predict the occurrence of ACCE at follow-up.

Özet

Amaç: Bu çalışmanın amacı asemptomatik diyabetik ve pre-diyabetik hastalarda stres miyokardiyal perfüzyon tek foton emisyon bilgisayarlı tomografi/bilgisayarlı tomografi miyokard perfüzyon sintigrafisi (MPS) ile miyokardiyal iskemi prevalansını belirlemek ve iskemi bulgularının takipte istenmeyen kardiyak ve serebrovasküler olayları öngörüp görmediğini saptamaktır.Yöntem: Daha önce bilinen koroner arter hastalığı olmayan 43 diyabetik ve 35 pre-diyabetik asemptomatik hastaya MPS yapılarak, hastalar istenmeyen kardiyak/serebrovasküler olaylar açısından ortalama 12,8±2,2 ay takip edildi. İskemiyi öngören bazal değişkenler ve MPS'nin takipte istenmeyen kardiyovasküler olayları öngörmedeki değeri lojistik regresyon modeli ile değerlendirildi.Bulgular: Diyabetik hastaların onunda (%23,3) ve pre-diyabetik hastaların dördünde (%11,4) MPS ile iskemi saptandı. Miyokardiyal iskemi açısından tek bağımsız risk faktörü diabetes mellitus varlığı idi (odds ratio (OR): 12,31, %95 güven aralığı (GA): 1,83-82,66; p<0,01). Ortalama 12,8±2,2 aylık takip süresi boyunca yetmiş sekiz hastanın beşinde (%6,4) istenmeyen kardiyovasküler olay gelişti. Sintigrafide iskemi bulgusu olanların takibinde kardiyovasküler olay gelişme riski, normal MPS bulguları olanlara göre belirgin olarak yüksekti (olay oranı: %21,4 ile %3,1, OR: 8,455 %95 GA: 1,264-56,562, p=0,038).Sonuç: Adenozin stres SPECT/CT ile saptanan iskeminin asemptomatik diyabetik ve pre-diyabetik hastalarda takipte gelişecek olan kardiyovasküler olayları öngördüğü söylenebilir.

🔖

Cite This Article

ÖZDEMİR, E., POLAT, Ş. B., YILDIRIM, N., TÜRKÖLMEZ, Ş., ERSOY, R., DURMAZ, T., KELEŞ, T., BOZKURT, E., ÇAKIR, B. (2016). Evaluation of Silent Myocardial Ischemia with Single-Photon Emission Computed Tomography/Computed Tomography in Asymptomatic Subjects with Diabetes and Pre-Diabetes. Molecular Imaging and Radionuclide Therapy, Cilt: 25 - Sayı: 2, 70–78. https://ajindex.com/articles/295144

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. Stolar M. Addressing cardiovascular risk in patients with type 2 diabetes: Focus on primary care. Am J Med Sci 2011;341:132-140
  2. Wilson PW. Diabetes mellitus and coronary heart disease. Endocrinol Metab Clin North Am 2001;30:857-881
  3. Xanthos T, Ekmektzoglou KA, Papadimitriou L. Reviewing myocardial silent ischemia: Specific patient subgroups. Int J Cardiol 2008;124:139-148
  4. Wackers FJ, Young LH, Inzucchi SE, Chyun DA, Davey JA, Barrett EJ, Taillefer R, Wittlin SD, Heller GV, Filipchuk N, Engel S, Ratner RE, Iskandrian AE; Detection of Ischemia in Asymptomatic Diabetics Investigators. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: The DIAD study. Diabetes Care 2004;27:1954-1961
  5. Marini MA, Succurro E, Castaldo E, Cufone S, Arturi F, Sciacqua A, Lauro R, Hribal ML, Perticone F, Sesti G. Cardiometabolic risk profiles and carotid atherosclerosis in individuals with prediabetes identified by fasting glucose, postchallenge glucose, and hemoglobin A1c criteria. Diabetes Care 2012;35:1144-1149
  6. Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, Fayad ZA, Foster E, Hlatky MA, Hodgson JM, Kushner FG, Lauer MS, Shaw LJ, Smith SC Jr, Taylor AJ, Weintraub WS, Wenger NK, Jacobs AK, Smith SC Jr, Anderson JL, Albert N, Buller CE, Creager MA, Ettinger SM, Guyton RA, Halperin JL, Hochman JS, Kushner FG, Nishimura R, Ohman EM, Page RL, Stevenson WG, Tarkington LG, Yancy CW; American College of Cardiology Foundation; American Heart Association. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2010;56:50-103
  7. Authors/Task Force Members, Rydén L, Grant PJ, Anker SD, Berne C, Cosentino F, Danchin N, Deaton C, Escaned J, Hammes HP, Huikuri H, Marre M, Marx N, Mellbin L, Ostergren J, Patrono C, Seferovic P, Uva MS, Taskinen MR, Tendera M, Tuomilehto J, Valensi P, Zamorano JL; ESC Committee for Practice Guidelines (CPG), Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S; Document Reviewers, De Backer G, Sirnes PA, Ezquerra EA, Avogaro A, Badimon L, Baranova E, Baumgartner H, Betteridge J, Ceriello A, Fagard R, Funck-